tiprankstipranks
Cipher Pharmaceuticals Announces Q3 2024 Financial Results
Company Announcements

Cipher Pharmaceuticals Announces Q3 2024 Financial Results

Story Highlights

Cipher Pharmaceuticals (TSE:CPH) has released an update.

Don't Miss our Black Friday Offers:

Cipher Pharmaceuticals is set to release its Q3 2024 financial results on November 7, 2024, followed by a conference call on November 8 to discuss the outcomes and company developments. With a strong portfolio primarily in dermatology, Cipher continues to manage clinical development and regulatory approvals, marketing its products across Canada, the U.S., and South America.

For further insights into TSE:CPH stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyCipher Pharmaceuticals price target lowered to C$17 from C$19 at Stifel
TipRanks Auto-Generated NewsdeskCipher Pharmaceuticals Q3 2024 Results: Growth and Acquisitions
TipRanks Canadian Auto-Generated NewsdeskCipher Pharmaceuticals’ Revenue Soars After Natroba Acquisition
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App